{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:02:57Z","timestamp":1793084577869,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Project for Medical and Health Science and Technology","award":["2022KY063"],"award-info":[{"award-number":["2022KY063"]}]},{"name":"Zhejiang Provincial Peoples Hospital Seed Fund","award":["c-2022-YYQD26"],"award-info":[{"award-number":["c-2022-YYQD26"]}]},{"name":"he Science and technology project of Jiaxing City","award":["2021A35"],"award-info":[{"award-number":["2021A35"]}]},{"name":"Wenling social development science and technology project","award":["2021S00108"],"award-info":[{"award-number":["2021S00108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34974-5","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:17:50Z","timestamp":1768810670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of a hierarchical pharmacist management model on reducing hyperphosphatemia in hemodialysis patients in China: a multicenter randomized study"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaolan","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-min","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengfei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiudi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"34974_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","volume":"93","author":"MG Vervloet","year":"2018","unstructured":"Vervloet, M. G. & van Ballegooijen, A. J. Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 93, 1060\u20131072. https:\/\/doi.org\/10.1016\/j.kint.2017.11.036 (2018).","journal-title":"Kidney Int."},{"key":"34974_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.jrn.2020.02.003","volume":"31","author":"A Rastogi","year":"2021","unstructured":"Rastogi, A., Bhatt, N., Rossetti, S. & Beto, J. Management of hyperphosphatemia in end-stage renal disease: A new paradigm. J. Ren. Nutr. 31, 21\u201334. https:\/\/doi.org\/10.1053\/j.jrn.2020.02.003 (2021).","journal-title":"J. Ren. Nutr."},{"key":"34974_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11255-022-03328-9","volume":"55","author":"S Tao","year":"2023","unstructured":"Tao, S. et al. Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China. Int. Urol. Nephrol. 55, 389\u2013398. https:\/\/doi.org\/10.1007\/s11255-022-03328-9 (2023).","journal-title":"Int. Urol. Nephrol."},{"key":"34974_CR4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41598-020-79531-4","volume":"11","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. Baseline data report of the China dialysis outcomes and practice patterns study (DOPPS). Sci. Rep. 11, 873. https:\/\/doi.org\/10.1038\/s41598-020-79531-4 (2021).","journal-title":"Sci. Rep."},{"key":"34974_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12882-019-1355-5","volume":"20","author":"DS Fuller","year":"2019","unstructured":"Fuller, D. S. et al. Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries. BMC Nephrol. 20, 169. https:\/\/doi.org\/10.1186\/s12882-019-1355-5 (2019).","journal-title":"BMC Nephrol."},{"key":"34974_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s40618-023-02212-2","volume":"47","author":"VM Bimonte","year":"2024","unstructured":"Bimonte, V. M. et al. Hypocalcemia in combination with hyperphosphatemia impairs muscle cell differentiation in vitro. J. Endocrinol. Invest. 47, 947\u2013957. https:\/\/doi.org\/10.1007\/s40618-023-02212-2 (2024).","journal-title":"J. Endocrinol. Invest."},{"key":"34974_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13461","volume":"74","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon, C. et al. Admission serum phosphate levels and the risk of respiratory failure. Int. J. Clin. Pract. 74, e13461. https:\/\/doi.org\/10.1111\/ijcp.13461 (2020).","journal-title":"Int. J. Clin. Pract."},{"key":"34974_CR8","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1161\/STROKEAHA.116.013195","volume":"47","author":"S Yamada","year":"2016","unstructured":"Yamada, S. et al. Association between serum phosphate levels and stroke risk in patients undergoing hemodialysis: The Q-cohort study. Stroke 47, 2189\u20132196. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013195 (2016).","journal-title":"Stroke"},{"key":"34974_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2020.11.020","volume":"316","author":"H Hiyamuta","year":"2021","unstructured":"Hiyamuta, H. et al. Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis: Ten-year outcomes of the Q-cohort study. Atherosclerosis 316, 25\u201331. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.11.020 (2021).","journal-title":"Atherosclerosis"},{"key":"34974_CR10","doi-asserted-by":"publisher","unstructured":"Kidney disease: Improving global outcomes, C. K. D. M. B. D. U. W. G. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. Suppl. 7, 1\u201359, https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001 (2017).","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"34974_CR11","volume-title":"Chinese Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder","author":"L Zhihong","year":"2019","unstructured":"Zhihong, L. & Guiseng, L. Chinese Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder (The People\u2019s Health Publishing House, 2019)."},{"key":"34974_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/13696998.2017.1347877","volume":"20","author":"R Rizk","year":"2017","unstructured":"Rizk, R., Hiligsmann, M., Karavetian, M. & Evers, S. Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: Results from the nutrition education for management of osteodystrophy trial. J. Med. Econ. 20, 1024\u20131038. https:\/\/doi.org\/10.1080\/13696998.2017.1347877 (2017).","journal-title":"J. Med. Econ."},{"key":"34974_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/jhn.12472","volume":"30","author":"R Rizk","year":"2017","unstructured":"Rizk, R., Karavetian, M., Hiligsmann, M. & Evers, S. Effect of stage-based education provided by dedicated dietitians on hyperphosphataemic haemodialysis patients: results from the nutrition education for management of osteodystrophy randomised controlled trial. J. Hum. Nutr. Diet 30, 554\u2013562. https:\/\/doi.org\/10.1111\/jhn.12472 (2017).","journal-title":"J. Hum. Nutr. Diet"},{"key":"34974_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/jorc.12072","volume":"40","author":"CJ Nagel","year":"2014","unstructured":"Nagel, C. J. et al. Management of hyperphosphataemia: Practices and perspectives amongst the renal care community. J. Ren. Care 40, 230\u2013238. https:\/\/doi.org\/10.1111\/jorc.12072 (2014).","journal-title":"J. Ren. Care"},{"key":"34974_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2215\/CJN.18171120","volume":"16","author":"Y Narasaki","year":"2020","unstructured":"Narasaki, Y. & Rhee, C. M. Dietary therapy for managing hyperphosphatemia. Clin. J. Am. Soc. Nephrol. 16, 9\u201311. https:\/\/doi.org\/10.2215\/CJN.18171120 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"34974_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.jrn.2018.06.004","volume":"29","author":"A Brauer","year":"2019","unstructured":"Brauer, A., Waheed, S., Singh, T. & Maursetter, L. Improvement in hyperphosphatemia using phosphate education and planning talks. J. Ren. Nutr. 29, 156\u2013162. https:\/\/doi.org\/10.1053\/j.jrn.2018.06.004 (2019).","journal-title":"J. Ren. Nutr."},{"key":"34974_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10157-015-1212-1","volume":"20","author":"WC Tsai","year":"2016","unstructured":"Tsai, W. C. et al. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients. Clin. Exp. Nephrol. 20, 815\u2013821. https:\/\/doi.org\/10.1007\/s10157-015-1212-1 (2016).","journal-title":"Clin. Exp. Nephrol."},{"key":"34974_CR18","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.ekir.2023.10.001","volume":"8","author":"JB Wish","year":"2023","unstructured":"Wish, J. B. Tenapanor as add-on treatment for hyperphosphatemia in dialysis patients: enough bang for the buck?. Kidney Int. Rep. 8, 2194\u20132197. https:\/\/doi.org\/10.1016\/j.ekir.2023.10.001 (2023).","journal-title":"Kidney Int. Rep."},{"key":"34974_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144119","volume":"10","author":"S Ghimire","year":"2015","unstructured":"Ghimire, S., Castelino, R. L., Lioufas, N. M., Peterson, G. M. & Zaidi, S. T. Nonadherence to medication therapy in haemodialysis patients: A systematic review. PLoS ONE 10, e0144119. https:\/\/doi.org\/10.1371\/journal.pone.0144119 (2015).","journal-title":"PLoS ONE"},{"key":"34974_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051367","author":"JJ Neumiller","year":"2024","unstructured":"Neumiller, J. J., St Peter, W. L. & Shubrook, J. H. Type 2 diabetes and chronic kidney disease: An opportunity for pharmacists to improve outcomes. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm13051367 (2024).","journal-title":"J. Clin. Med."},{"key":"34974_CR21","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.1038\/s41598-022-15657-x","volume":"12","author":"M Stuhec","year":"2022","unstructured":"Stuhec, M. & Zorjan, K. Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy. Sci. Rep. 12, 11387. https:\/\/doi.org\/10.1038\/s41598-022-15657-x (2022).","journal-title":"Sci. Rep."},{"key":"34974_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.sapharm.2024.02.007","volume":"20","author":"XD He","year":"2024","unstructured":"He, X. D. et al. Role of clinical pharmacists in multidisciplinary collaborative management of blood glucose in COVID-19 patients with hyperglycemia. Res. Soc. Adm. Pharm. 20, 65\u201371. https:\/\/doi.org\/10.1016\/j.sapharm.2024.02.007 (2024).","journal-title":"Res. Soc. Adm. Pharm."},{"key":"34974_CR23","unstructured":"Minghui, Z. & Luxia, Z. Chinese Kidney Disease Science Report (2021)."},{"key":"34974_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12877-023-04557-y","volume":"23","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions. BMC Geriatr. 23, 849. https:\/\/doi.org\/10.1186\/s12877-023-04557-y (2023).","journal-title":"BMC Geriatr."},{"key":"34974_CR25","unstructured":"Liu, Z. & Li, G. Diagnosis and Treatment of Mineral and Bone Abnormalities in Chronic Kidney Disease in China. (2019)."},{"key":"34974_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin, A. et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 71, 31\u201338. https:\/\/doi.org\/10.1038\/sj.ki.5002009 (2007).","journal-title":"Kidney Int."},{"key":"34974_CR27","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0002-8223(96)00331-8","volume":"96","author":"M Boaz","year":"1996","unstructured":"Boaz, M. & Smetana, S. Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake. J. Am. Diet Assoc. 96, 1268\u20131270. https:\/\/doi.org\/10.1016\/S0002-8223(96)00331-8 (1996).","journal-title":"J. Am. Diet Assoc."},{"key":"34974_CR28","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","volume":"88","author":"CS Shinaberger","year":"2008","unstructured":"Shinaberger, C. S. et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am. J. Clin. Nutr. 88, 1511\u20131518. https:\/\/doi.org\/10.3945\/ajcn.2008.26665 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"34974_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/ndt\/gfu251","volume":"30","author":"V Bellizzi","year":"2015","unstructured":"Bellizzi, V. et al. Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: A historical cohort controlled study. Nephrol. Dial. Transplant. 30, 71\u201377. https:\/\/doi.org\/10.1093\/ndt\/gfu251 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"34974_CR30","unstructured":"Group., K. C. P. G. W. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int. 1, 289 (2012)."},{"key":"34974_CR31","unstructured":"Branch, W. G. o. A. G. o. t. C. M. A. N. Clinical Practice Guidelines for the Diagnosis and Treatment of Renal Anemia in China. Chin. Med. J. 20, 1463\u20131502 (2021)."},{"key":"34974_CR32","volume-title":"Blood Purification Standard Operating Procedure","author":"C Xiangmei","year":"2021","unstructured":"Xiangmei, C. Blood Purification Standard Operating Procedure (People\u2019s Medical Publishing House, 2021)."},{"key":"34974_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41598-017-00080-4","volume":"7","author":"CT Liu","year":"2017","unstructured":"Liu, C. T. et al. Roles of serum calcium, phosphorus, PTH and ALP on mortality in peritoneal dialysis patients: A nationwide, population-based longitudinal study using TWRDS 2005\u20132012. Sci. Rep. 7, 33. https:\/\/doi.org\/10.1038\/s41598-017-00080-4 (2017).","journal-title":"Sci. Rep."},{"key":"34974_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/heapol\/czad018","volume":"38","author":"H Hu","year":"2023","unstructured":"Hu, H. et al. Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China. Health Policy Plan 38, 609\u2013619. https:\/\/doi.org\/10.1093\/heapol\/czad018 (2023).","journal-title":"Health Policy Plan"},{"key":"34974_CR35","doi-asserted-by":"publisher","first-page":"1148847","DOI":"10.3389\/fpubh.2023.1148847","volume":"11","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Coping with COVID: Performance of China\u2019s hierarchical medical system during the COVID-19 pandemic. Front Public Health 11, 1148847. https:\/\/doi.org\/10.3389\/fpubh.2023.1148847 (2023).","journal-title":"Front Public Health"},{"key":"34974_CR36","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.13286\/j.1001-5213.2020.11.04","volume":"40","author":"LIU Jie","year":"2020","unstructured":"Jie, L. I. U., Dong-ning, Y. A. O., Rong, H. & Wen-bing, Y. A. O. The necessity and possibility of transforming nonclinical pharmacists to clinical pharmacists. Chin. J. Hosp. Pharm. 40, 1192\u20131195. https:\/\/doi.org\/10.13286\/j.1001-5213.2020.11.04 (2020).","journal-title":"Chin. J. Hosp. Pharm."},{"key":"34974_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.105054","volume":"140","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. An effective model for predicting serum albumin level in hemodialysis patients. Comput. Biol. Med. 140, 105054. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.105054 (2022).","journal-title":"Comput. Biol. Med."},{"key":"34974_CR38","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.ekir.2024.02.267","volume":"9","author":"NW Sri Wardani","year":"2024","unstructured":"Sri Wardani, N. W. & Suryawan, K. WCN24-2441 role of serum albumin on quality of life in regular hemodialysis patients. Kidney Int. Rep. 9, S130. https:\/\/doi.org\/10.1016\/j.ekir.2024.02.267 (2024).","journal-title":"Kidney Int. Rep."},{"key":"34974_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.semnephrol.2004.06.021","volume":"24","author":"Y Sagliker","year":"2004","unstructured":"Sagliker, Y. et al. Sagliker syndrome: uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure. Semin. Nephrol. 24, 449\u2013455. https:\/\/doi.org\/10.1016\/j.semnephrol.2004.06.021 (2004).","journal-title":"Semin. Nephrol."},{"key":"34974_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1159\/000530230","volume":"147","author":"T Berner","year":"2023","unstructured":"Berner, T. et al. Real-world phosphate binder use among dialysis-dependent patients with CKD. Nephron 147, 583\u2013590. https:\/\/doi.org\/10.1159\/000530230 (2023).","journal-title":"Nephron"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34974-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:43:37Z","timestamp":1770633817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34974-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34974"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34974-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5436"}}